ORX:STO
Orexo AB
0,98 SEK
arrow_downward
-1,70%(-0,017) 1D
20 ნოე, 17:29:34 GMT+1 · SEK
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ORX...
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 მლნ.
Avg. vol.
785,30 ათ.
Volume
286,21 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
Open
1,05 SEK
High
1,05 SEK
Low
0,93 SEK
Mkt. cap
345,30 მლნ.
Avg. vol.
785,30 ათ.
Volume
286,21 ათ.
P/E ratio
0,07
52-wk high
22,55 SEK
52-wk low
0,80 SEK
EPS
13,61 SEK
Shares outstanding
35,13 მლნ.
No. of employees
55
News stories
From web sources and news partners
TradingView
·
3 საათის წინ
Stock Market Crash: Nasdaq, S&P 500 Suffer Worst Weekly Losses in Years
Traders Union
·
8 საათის წინ
VIX fear index hits highest level since April 2025 as S&P 500 plunges
Beinsure
·
5 საათის წინ
S&P 500 forecast for 2027: Wall Street expects a rebound after an 11.6% drop fueled by AI fears
JournalArta
·
1 საათის წინ
S&P 500 Loses Nearly All Its 2026 Gains in Sudden Reversal
Profile
Orexo is a Swedish pharmaceutical company that develops improved pharmaceuticals based on innovative formulation technologies that meet large medical needs. Through presence its in the US market, drugs and digital therapies are commercialized to treat opioid use disorder and adjacent diseases. Products targeting other therapeutic areas are developed and commercialized worldwide with partners. Wikipedia
About Orexo AB
CEOნიკოლაი სორენსენი
Employees55
Founded1995
Headquarters-
SectorHealth Care
IndustryPharmaceutical industry
Websiteorexo.com